S&P/ASX 200 on track for seventh consecutive month of gains
Amazon on Thursday released first-quarter results that exceeded analysts’ expectations, with sales soaring 44% year-over-year to US$108.5 billion and profits more than tripling to US$8.1 billion. Brent crude oil price rose 1.3% to US$68.16 a barrel on Thursday.
S&P/ASX 200 (INDEXASX:XJO) dipped 0.60% to 7,039.5 points by 12.51 pm even as US markets rose overnight on strong corporate earnings data.
Locally, this is a second weekly decline a row, but the ASX 200 remains firmer for the month with a gain of 3.6%.
This would make it a seventh straight month of gains with the market rising about 20% in this time.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.
Kinetiko Energy s productive March quarter sets the stage for near-term first production and revenue
During the March quarter, the company continued to promote the potential of the Amersfoort project to be developed as a significant scalable onshore gas producer in South Africa, close to multiple markets and surrounded by energy infrastructure. Completed upgrade to road and terminal landing with flaring Well KA-03PTR.
Kinetiko Energy Ltd (ASX:KKO) enjoyed a productive March quarter that has set the stage for first production and revenues in the near term at its Amersfoort Project in South Africa.
Activities at the project are carried out through Afro Energy (Pty) Ltd, in which Kinetiko holds 49%, and during the quarter as a result of being granted a bulk gas production and removal permit, Afro Energy began preparing a short-term pilot gas production program.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.